Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125319882 | 12531988 | 2 | F | 20160702 | 20160705 | 20160706 | 20160708 | EXP | PH-TAKEDA-2016MPI006130 | TAKEDA | 27.46 | YR | M | Y | 0.00000 | 20160708 | OT | PH | PH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125319882 | 12531988 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | Y | 21602 | INJECTION | ||||||||
| 125319882 | 12531988 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | 2.34 MG, UNK | Y | 21602 | 2.34 | MG | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125319882 | 12531988 | 1 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125319882 | 12531988 | HO |
| 125319882 | 12531988 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125319882 | 12531988 | Pyrexia | |
| 125319882 | 12531988 | Spinal disorder | |
| 125319882 | 12531988 | Splenomegaly |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125319882 | 12531988 | 1 | 20160624 | 0 |